Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    An NIH site-wide banner announces updates and FAQs about a terminology transition, stating that “Super Intelligence” is replacing “Artificial Intelligence” in some NIH content. The study page itself continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-24T13:09:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:30:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:07:56.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the record is inaccessible; the screen shows the 403 header and standard error-page navigation.
    Difference
    21%
    Check dated 2026-09-19T20:10:27.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.6, indicating a newer version of the page content.
    Difference
    0.1%
    Check dated 2026-08-29T21:44:51.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision line (Revision: v3.6.5) was added, and a large set of institutional names, investigator names, sponsor/collaborator references, and MeSH/keywords were removed, altering the displayed affiliations, contributors, and metadata for the study page.
    Difference
    20%
    Check dated 2026-08-08T15:25:20.000Z thumbnail image

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.